within Pharmacolibrary.Drugs.ATC.V;

model V04CM01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.024,
    adminDuration  = 600,
    adminMass      = 0.0001,
    adminCount     = 1,
    Vd             = 0.0066,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Gonadorelin is a synthetic decapeptide identical to the naturally occurring gonadotropin-releasing hormone (GnRH). It stimulates the release of the gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary. It is used diagnostically to evaluate pituitary function and rarely therapeutically. It is an approved drug for diagnostic use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data reported for healthy adult males after intravenous bolus administration.</p><h4>References</h4><ol><li>P S Gillies, D Faulds, J A Balfour, C M Perry,Ganirelix.,Drugs,2000<a href='https://pubmed.ncbi.nlm.nih.gov/10718102/'>https://pubmed.ncbi.nlm.nih.gov/10718102/</a></li><li>J A Huirne, C B Lambalk,Gonadotropin-releasing-hormone-receptor antagonists.,Lancet (London, England),2001<a href='https://pubmed.ncbi.nlm.nih.gov/11734258/'>https://pubmed.ncbi.nlm.nih.gov/11734258/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V04CM01;
